Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.71M Buy
167,500
+140,600
+523% +$6.65M 0.09% 81
2025
Q4
$1.21M Sell
26,900
-23,498
-47% -$1.09M 0.02% 125
2025
Q3
$2.25M Sell
50,398
-35,102
-41% -$1.68M 0.06% 88
2025
Q2
$4.11M Sell
85,500
-254,800
-75% -$11.1M 0.15% 59
2025
Q1
$13.7M Buy
+340,300
New +$14.3M 0.46% 28

Other funds holding QGEN

SIH Partners's QGEN Position: Q1 2026 in Review

SIH Partners increased its Qiagen (QGEN) stake by 82% in Q1 2026, buying an estimated $733K and bringing the position to 34,418 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #162.

SIH Partners first reported a position in QGEN in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.09M in Q2 2025. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • SIH Partners held 34,418 shares of Qiagen worth $1.38M as of Q1 2026.
  • SIH Partners bought 15,485 Qiagen shares in Q1 2026, an estimated $733K.
  • Qiagen made up 0.02% of SIH Partners's portfolio in Q1 2026, its #162 holding.
  • SIH Partners first reported a position in Qiagen in Q4 2024 and has held it in 6 quarters since.
  • SIH Partners's Qiagen position peaked at $4.09M in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on SIH Partners's 13F filing for Q1 2026, filed 15 May 2026.